Relationship of Growth to Aneurysm Rupture in Asymptomatic Aneurysms ≤ 7 mm: A Systematic Analysis of the Literature

Chmayssani, Mohamad; Rebeiz, Jean G.; Rebeiz, Tania; Batjer, H. Hunt; Bendok, Bernard R.

doi:10.1227/neu.0b013e31820edbd3

Cited by 70 publications

(45 citation statements)

References 33 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Patients treated with open-cell stents were excluded. At the participating centers, all ruptured aneurysms are treated, and treatment of unruptured aneurysms is performed after careful assessment of perceived risk factors for rupture 18,19 and consultation with our multidisciplinary cerebrovascular team and patients.…”

Section: Patients and Techniquesmentioning

confidence: 99%

Closed-Cell Stent for Coil Embolization of Intracranial Aneurysms: Clinical and Angiographic Results

Wakhloo

Linfante

Silva

et al. 2012

AJNR Am J Neuroradiol

View full text Add to dashboard Cite

BACKGROUND AND PURPOSE:Recanalization is observed in 20 -40% of endovascularly treated intracranial aneurysms. To further reduce the recanalization and expand endovascular treatment, we evaluated the safety and efficacy of closed-cell SACE. MATERIALS AND METHODS:Between 2007 and 2010, 147 consecutive patients (110 women; mean age, 54 years) presenting at 2 centers with 161 wide-neck ruptured and unruptured aneurysms were treated by using SACE. Inclusion criteria were wide-neck aneurysms (Ͼ4 mm or a dome/neck ratio Յ2). Clinical outcomes were assessed by the mRS score at baseline, discharge, and follow-up. Aneurysm occlusion was assessed on angiograms by using the RS immediately after SACE and at follow-up.

show abstract

Section: Patients and Techniquesmentioning

confidence: 99%

Closed-Cell Stent for Coil Embolization of Intracranial Aneurysms: Clinical and Angiographic Results

Wakhloo

Linfante

Silva

et al. 2012

AJNR Am J Neuroradiol

View full text Add to dashboard Cite

show abstract

“…Treatment of unruptured aneurysms in our center is performed after careful assessment of perceived risk factors for rupture 10,11) and consultation with our multidisciplinary cerebrovascular team and the patient.…”

Section: Methodsmentioning

confidence: 99%

Enterprise Stent-assisted Cerebral Aneurysm Coiling: Can Antiplatelet Therapy be Terminated after Neointima Formation with the Enterprise Stent?

Takayama

Taoka

Myouchin

et al. 2016

JNET

View full text Add to dashboard Cite

Objective: Patients who undergo Enterprise stent (ES)-assisted cerebral aneurysm coiling require long-term antiplatelet therapy (AT). Some studies have reported that cessation or modification of AT increases the risk of cerebral infarction.The aim of this study was to evaluate whether AT can terminated without increasing the risk of ischemic events among patients who have undergone ES-assisted cerebral aneurysm coiling. Methods:This study evaluated 9 with 11 unruptured aneurysms were confirmed to have neointima formation with the ES on follow-up angiography. Dual AT was given for ≥3 months postoperatively, then one antiplatelet agent was administered until ≥6 months postoperatively before termination of all AT. Incidences of ipsilateral ischemic events and stent occlusion after AT termination were assessed prospectively.Results: During follow-up (mean, 32.8 months; range, 21.5-51.3 months) ipsilateral ischemic events and stent occlusion did not occur in any cases. Conclusion:Termination of AT ≥6 months postoperatively did not result in ischemic events among patients with neointima formation after ES-assisted cerebral aneurysm coiling.

show abstract

“…33 A decision analysis based on data from this screening study showed 150 relatives need to be screened to prevent one episode of SAH. 34 Although screening marginally increased the absolute number of life years, it did not increase the number of quality adjusted life years. 34 Thus screening of persons with only one affected relative could not be recommended on the basis of this study.…”

Section: Yield Of Screening In Different Populationsmentioning

confidence: 98%

“…34 Although screening marginally increased the absolute number of life years, it did not increase the number of quality adjusted life years. 34 Thus screening of persons with only one affected relative could not be recommended on the basis of this study. In a study screening 116 persons with ≥2 first degree relatives with SAH an aneurysm was revealed in 8% of the screenees.…”

Section: Yield Of Screening In Different Populationsmentioning

confidence: 98%

See 1 more Smart Citation

Unruptured intracranial aneurysms: initial and follow-up screening

Bor¹

2010

Future Neurol.

View full text Add to dashboard Cite

Subarachnoid hemorrhage (SAH) from a ruptured intracranial aneurysm is a devastating disease that causes death or severe disability in half of patients. Intracranial aneurysms are not present at birth but develop during life. Actively searching and treating intracranial aneurysms before rupture may prevent SAH as a result of these aneurysms. The prevalence of intracranial aneurysms is approximately 2% in the general population, but higher in subgroups such as patients who have survived an episode of SAH, persons with a family history of SAH and patients with polycystic kidney disease. Screening for intracranial aneurysms should be considered in these high-risk groups. Some of the intracranial aneurysms detected with screening will be too small to be treated, and may therefore be followed over time, which can cause anxiety in the patient. In this article, we discuss current knowledge, remaining questions and future perspectives in screening and follow-up imaging for unruptured intracranial aneurysms.

show abstract

Relationship of Growth to Aneurysm Rupture in Asymptomatic Aneurysms ≤ 7 mm: A Systematic Analysis of the Literature

Cited by 70 publications

References 33 publications

Closed-Cell Stent for Coil Embolization of Intracranial Aneurysms: Clinical and Angiographic Results

Closed-Cell Stent for Coil Embolization of Intracranial Aneurysms: Clinical and Angiographic Results

Enterprise Stent-assisted Cerebral Aneurysm Coiling: Can Antiplatelet Therapy be Terminated after Neointima Formation with the Enterprise Stent?

Unruptured intracranial aneurysms: initial and follow-up screening

Contact Info

Product

Resources

About